PROFUND ADVISORS LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 277 filers reported holding GW PHARMACEUTICALS PLC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
PROFUND ADVISORS LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$421,000
+94.9%
1,942
+3.7%
0.02%
+77.8%
Q4 2020$216,000
-30.1%
1,872
-41.0%
0.01%
-43.8%
Q3 2020$309,000
-33.1%
3,173
-15.7%
0.02%
-38.5%
Q2 2020$462,000
+71.1%
3,766
+22.2%
0.03%
+30.0%
Q1 2020$270,000
-35.9%
3,081
-23.4%
0.02%
+11.1%
Q4 2019$421,000
-3.0%
4,022
+6.5%
0.02%
-18.2%
Q3 2019$434,000
-41.2%
3,777
-11.7%
0.02%
-37.1%
Q2 2019$738,000
+3.7%
4,279
+1.4%
0.04%
+2.9%
Q1 2019$712,000
+107.0%
4,221
+19.5%
0.03%
+61.9%
Q4 2018$344,0003,5320.02%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q3 2020
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 86,069$18,668,0008.69%
BARDIN HILL MANAGEMENT PARTNERS LP 170,108$36,897,0006.84%
HARVEST MANAGEMENT LLC 44,100$9,565,0005.72%
Twin Securities, Inc. 39,541$8,576,0005.50%
TIG Advisors, LLC 572,743$124,228,0004.67%
ALPINE ASSOCIATES MANAGEMENT INC. 787,500$170,810,0004.63%
First Trust Capital Management L.P. 105,822$22,953,0004.49%
Pentwater Capital Management LP 2,102,104$455,946,0004.35%
OMNI PARTNERS LLP 403,061$87,424,0004.31%
SPRING CREEK CAPITAL LLC 370,000$80,253,0003.47%
View complete list of GW PHARMACEUTICALS PLC shareholders